Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer

Keyphrases

• 30-day Complications 40%
• Abdominal Abscess 20%
• Abdominoperineal Resection 20%
• Advanced Colorectal Cancer 20%
• Brachytherapy 100%
• Cancer Recurrence 20%
• Colorectal Cancer 20%
• Complication Rate 20%
• Disease-free Survival 20%
• Enteric Fistula 20%
• Event Rate 20%
• In(III) 20%
• Intestinal Obstruction 20%
• Intraoperative Brachytherapy 40%
• Intraoperative Radiation Therapy 100%
• Local Recurrence Rate 20%
• Locally Advanced 40%
• Locally Advanced Colorectal Cancer 100%
• Locally Advanced Rectal Cancer 20%
• Locally Recurrent 100%
• Low Anterior Resection 20%
• Neurogenic Bladder 20%
• Neuropathic Pain 20%
• Nonanatomic Resection 20%
• Operative Intervention 20%
• Overall Survival 20%
• Pelvic Exenteration 20%
• Pelvic Recurrence 20%
• Pelvic Surgery 20%
• Postoperative Morbidity 20%
• R1 Resection 20%
• Recurrence Rate 20%
• Recurrent Colorectal Cancer 100%
• Resection 20%
• Surgical Intervention 20%
• Therapy Options 20%
• Ureteral Obstruction 20%
• Wound Complications 40%

Medicine and Dentistry

• Abdominal Abscess 20%
• Abdominoperineal Resection 20%
• Brachytherapy 100%
• Cancer Recurrence 20%
• Colorectal Carcinoma 100%
• Disease Free Survival 20%
• Intestine Fistula 20%
• Intraoperative Radiation Therapy 100%
• Lower Anterior Resection 20%
• Neurogenic Bladder 20%
• Neuropathic Pain 20%
• Overall Survival 20%
• Pelvic Exenteration 20%
• Pelvis 100%
• Pelvis Surgery 20%
• Rectum Cancer 40%
• Recurrence Risk 40%
• Recurrent Disease 20%
• Small Intestine Obstruction 20%
• Stenting 20%
• Surgery 100%
• Ureter Obstruction 20%
• Wound Complication 40%